A Study of QL1706H in Patients With Advanced Solid Tumors

Clinical trial NCT06047431 · UNKNOWN

Trial details

NCT number: NCT06047431
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-10-01
Primary completion: 2024-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.